Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

• Status: Completed
• Trial end date: 2014-08-01

Summary

The purpose of the study is to compare the efficacy, safety and tolerability of aclidinium bromide/formoterol fumarate and salmeterol/fluticasone propionate in patients with chronic obstructive pulmonary disease (COPD)

• Phase: Phase 3

Details

• Lead Sponsor: AstraZeneca
• Treatments: Bromides; Fluticasone; Formoterol Fumarate; Salmeterol Xinafoate